THE SIGNIFICANCE OF IMMUNOMODULATORY THERAPY IN PREGRAVIDAL PREPARATION OF THE PATIENTS WITH RECURRENT HSV TYPE 2
https://doi.org/10.17749/2313-7347.2015.9.1.019-031
Abstract
Herpes simplex virus type 1 (HSV-1) and 2 (HSV-2) - is a widespread viruses that can form a lifelong infection and persistence. Genital herpes in women of childbearing age is a serious risk of vertical transmission from mother to fetus. Primary HSV infection and the first episode of genital HSV infections are particularly high risk of infection of the fetus and newborn. The infection rarely occurs in the uterus. Most often the virus is transmitted during childbirth. The greatest risk of transmission to the fetus and the newborn in the case of primary maternal infection occurred during the second half of pregnancy. The risk of transmission from mother to fetus and newborn, can be reduced or the appointment of antiviral drugs, or in specific cases, caesarean section. The purpose of this paper is to propose a possible strategy to prevent transmission of the virus from an infected mother to the fetus.
About the Authors
N. N. Minaev
Voronezh State Medical Academy named after NN Burdenko Russian Ministry of Health
Russian Federation
hD, MD, professor, Head of the Department of Obstetrics and Gynecology
Russian Federation
hD, MD, professor, Head of the Department of Obstetrics and Gynecology
D. Ju. Bugrimov
Voronezh State Medical Academy named after NN Burdenko Russian Ministry of Health
Russian Federation
PhD, advisor RAE master MANEB, Senior Researcher, Director of the Institute of Experimental BiologyandMedicine
Russian Federation
PhD, advisor RAE master MANEB, Senior Researcher, Director of the Institute of Experimental BiologyandMedicine
A. A. Klimovich
Voronezh State Medical Academy named after NN Burdenko Russian Ministry of Health
Russian Federation
researcher of the Institute of Experimental Biology and Medicine
Russian Federation
researcher of the Institute of Experimental Biology and Medicine
References
1. Filatov O.Yu., Kashaeva O.V., Bugrimov D.Yu.,Klimovich A.A. Rossiiskii immunologicheskii zhurnal . 2013; 7 (4): 385-390.
2. Халдин А.А., Баскакова Д.В. Эпидемиологические аспекты заболеваний, вызываемых вирусом простого герпеса (обзор литературы). Consilium Medicum. Дерматология. 2007; 1: 27-30.
3. Anzivino E., Fioriti D., Mischitelli M. et al. Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention. Virology Journal. 2009; 6: 40.
4. Baker David A. Consequences of herpes simplex virus in pregnancy and their prevention. Current Opinion in Infectious Diseases. 2007; 20 (1): 73-76.
5. Boggess K.A., Watts D.H., Hobson A.C., Ashley R.L., Brown Z.A., Corey L. Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy. American journal of obstetrics and gynecology. 1997; 176 (2): 443-51.
6. Cone R.W., Hobson A.C., Brown Z., Ashley R., Berry S., Winter C., Corey L. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA. 1994; 272 (10): 792-6.
7. David W. Kimberlin, Chin-Yu Lin, Richard F. Jacobs, Dwight A. Powell, Lisa M. Frenkel, William C. Gruber, Mobeen Rathore, John S. Bradley, Pamela S. Diaz, Mary Kumar, Ann M. Arvin, Kathleen Gutierrez, Mark Shelton, Leonard B. Weiner, John W. Sleasman, Teresa Murgu a de Sierra, Seng-Jaw Soong, Jan Kiell, Fred D. Lakeman, Richard J. Whitley. Natural history of neonatal herpes simplex virus infections in the acyclovir era. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group Pediatrics. 2001; 108 (2): 223-9.
8. Gianluca Straface, Alessia Selmin, Vincenzo Zanardo, Marco De Santis, Alfredo Ercoli, Giovanni Scambia. Herpes Simplex Virus Infection in Pregnancy. Infectious Diseases in Obstetrics and Gynecology. 2012; 11: 385697.
9. Gupta R., Warren T., Wald A. Review Genital herpes. Lancet. 2007 Dec 22; 370 (9605): 2127-37.
10. Langenberg A.G., Kory L., Ashley R.L., Leong W.P., Straus S.E. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. New England Journal of Med. 1999; 341 (19): 1432-8.11. http://dommedika.com/phisiology/776.html Dommedika.
11. James S.H., Kimberlin D.W. Neonatal Herpes Simplex Virus Infection: Epidemiology and Treatment. Clin Perinatol. 2015 Mar; 42 (1): 47-59.
12. Nicholas J Moss, Cynthia C Harper, Katherine Ahrens, Katherine Scott, Susan Kao, Nancy Padian, Tina Raine, Jeffrey D Klausner. Predictors of incident hersimplex virus type 2 infections in young women at risk for unintended pregnancy in San Francisco. BMC Infectious Diseases. 2007; 7: 113.
13. Paz-Bailey G., Ramaswamy M., Hawkes S.J., Geretti A.M. Herpes simplex virus type 2: epidemiology and management options in developing countries. Sex Transm. Infect. 2007; 83: 16-22.
14. Ratnam S., Severini A., Zahariadis G. et al. The diagnosis of genital herpes – beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-srecific serology. Canadian journal infectious diseases medical microbiology. 2007; 18 (4); 233-240.
15. Roberts C.M., Pfister J.R., Spear S.J. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sexually Transmitted Diseases. 2003 Oct; 30 (10): 797-800.
16. Serdar H Ural, Thomas Chih Cheng Peng. Genital Herpes in Pregnancy Medscape. CME & Education Updated. 2013 Jan 23.
17. Wald A. Huang M.L. Carrell D. Selke S. Corey L. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. The Journal of infectious diseases. 2003; 188 (9): 1345-51.
18. Wald A., Zeh J., Selke S., Warren T., Ryncarz A.J., Ashley R., Krieger J.N., Corey L. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. New England Jourmal of Med. 2000 23 March; 342 (12): 844-50.
19.
20.
Review
For citations:
Minaev N.N., Bugrimov D.J., Klimovich A.A. THE SIGNIFICANCE OF IMMUNOMODULATORY THERAPY IN PREGRAVIDAL PREPARATION OF THE PATIENTS WITH RECURRENT HSV TYPE 2. Obstetrics, Gynecology and Reproduction. 2015;9(1):19-31. (In Russ.) https://doi.org/10.17749/2313-7347.2015.9.1.019-031
Views:
562
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
